In the world of cosmetic surgery, breast implants have been a popular choice for women looking to enhance their appearance. However, over the years, certain breast implants have faced recalls due to safety concerns. This article will explore the details of the breast implants that were recalled, the reasons behind these recalls, and what it means for patients who have had these implants.
The Allergan BIOCELL Texture Breast Implant Recall
The Recall Announcement
One of the most significant breast implant recalls in recent history was the global recall of Allergan’s BIOCELL® textured breast implants and tissue expanders. On July 24, 2019, Allergan made this announcement. The company stated that the “recalled products will no longer be distributed or sold in any of the currently available markets.” This recall was not a decision made lightly. It came after extensive research and concerns raised by health authorities around the world.
Reasons for the Recall
The main reason for the recall of Allergan’s BIOCELL textured breast implants was their potential link to a rare form of cancer called breast implant – associated anaplastic large – cell lymphoma (BIA – ALCL). The US Food and Drug Administration (FDA) and other health agencies had been monitoring cases of this lymphoma in women with breast implants. By July 6, 2019, the FDA had tracked 573 cases of women with breast implants who developed this rare cancer. Alarmingly, about 84% of these cases were associated with Allergan’s BIOCELL textured implants.
The textured surface of these implants, which was initially designed to help the implant stay in place and reduce the risk of capsular contracture (a common complication where the scar tissue around the implant tightens), was found to be a possible contributing factor to the development of BIA – ALCL. The rough texture of the implant could potentially cause chronic inflammation in the surrounding tissue. Over time, this inflammation might lead to the development of lymphoma cells.
The Extent of the Recall
The recall was global in nature. Allergan stopped distributing and selling the BIOCELL textured breast implants and tissue expanders in all markets where they were available. In the United States, this meant that plastic surgeons and medical facilities could no longer use these implants for new breast augmentation or reconstruction procedures. In other countries, the situation was similar. For example, in the United Kingdom, healthcare providers were also informed to stop using these products.
In China, the recall was also significant. The Shanghai Food and Drug Administration released information indicating that 76,576 units of these products needed to be recalled. This shows the wide – spread nature of the use of Allergan’s BIOCELL implants before the recall.
Understanding Breast Implant – Associated Anaplastic Large – Cell Lymphoma (BIA – ALCL)
What is BIA – ALCL
BIA – ALCL is a type of T – cell lymphoma. It is not the same as breast cancer. Instead of starting in the breast tissue itself, BIA – ALCL develops in the scar tissue (capsule) that forms around the breast implant or in the fluid that accumulates around the implant. This lymphoma is relatively rare compared to other types of cancers. However, the increase in cases associated with certain breast implants raised serious concerns among the medical community.
Symptoms of BIA – ALCL
The symptoms of BIA – ALCL may not show up immediately after getting breast implants. It can take years for symptoms to develop. Some of the common symptoms include swelling around the breast implant, a lump or mass near the implant, and fluid accumulation around the implant. In some cases, women may also experience pain or discomfort in the breast area. It’s important to note that these symptoms can also be caused by other, less serious conditions, such as capsular contracture or normal post – implant healing processes. But if a woman with breast implants experiences any of these symptoms, it’s crucial to consult a doctor immediately for proper evaluation.
Incidence and Risk Factors
The incidence of BIA – ALCL is relatively low. However, certain factors seem to increase the risk. As mentioned earlier, the use of textured breast implants, especially the Allergan BIOCELL implants, was associated with a higher risk. The longer a woman has had breast implants, the higher the risk may be. Additionally, some studies suggest that there may be a genetic predisposition in some women that makes them more susceptible to developing BIA – ALCL. But overall, the exact cause of this lymphoma in relation to breast implants is still not fully understood, and research is ongoing.
What This Recall Means for Patients
For Patients with Implanted BIOCELL Products
For women who already had Allergan’s BIOCELL textured breast implants, the news of the recall was understandably concerning. However, both the FDA and medical experts provided some guidance. The FDA and other health authorities did not recommend that asymptomatic patients (those without any signs or symptoms of BIA – ALCL) remove or replace their textured breast implants.
Medical professionals, such as Dr. Liu Chun jun , a deputy chief physician in the Plastic Surgery Department of the Chinese Academy of Medical Sciences Plastic Surgery Hospital, advised patients who had received these implants not to panic. Regular follow – up examinations were emphasized. For all breast implant patients, routine follow – up is standard. After implant placement, patients are typically required to return to the hospital for follow – up examinations at 1, 3, 6, and 12 months. After that, they should have check – ups every one to two years. This regular monitoring can help detect any potential issues early.
In the case of the Allergan recall, even though the risk of developing BIA – ALCL was increased with these implants, the overall risk was still relatively low. In China, for example, no cases of BIA – ALCL related to the use of these implants had been reported despite thousands of women having received them. The consensus among Chinese experts, as stated in the “BIA – ALCL Chinese Expert Consensus” in 2017, was that for patients with implanted prostheses, there was no need for extensive screening or prophylactic removal of the prostheses. They should simply continue with normal regular check – ups.
For Patients Considering Breast Implants
For women who were considering getting breast implants at the time of the recall or in the future, the Allergan recall was a wake – up call. It highlighted the importance of doing thorough research before choosing a breast implant. Patients now had to be more cautious and ask their plastic surgeons detailed questions about the type of implant they were considering.
They needed to know not only about the cost, appearance, and feel of the implant but also about its safety record. Surgeons were now more likely to have in – depth discussions with patients about the potential risks associated with different types of implants, including the risk of developing BIA – ALCL. Additionally, patients were more likely to look for implants with a long – standing, proven safety record. Implants with smooth surfaces, which were not associated with the same increased risk of BIA – ALCL as textured implants, became more popular among those considering breast augmentation.
Other Notable Breast Implant Recalls in History
The Early Concerns with Silicone Implants
Before the Allergan recall, there were other significant events related to breast implant safety. In the 1990s, there was a major controversy surrounding silicone – filled breast implants. In 1990, a female journalist in the United States developed breast cancer after receiving silicone – filled breast implants. This led to a series of lawsuits. Since silicone manufacturers could not prove that their products were not related to breast cancer, they were found liable in court. As a result, from 1992 to 2006, silicone – filled breast implants were banned in the United States for cosmetic use. During this time, women who wanted breast augmentation could choose alternative methods such as autologous fat tissue transplantation or saline – filled implants.
However, after years of research, more evidence emerged showing that silicone – filled implants were not directly linked to breast cancer. In 2006, the US FDA re – approved silicone – filled breast implants for use, and they have since become a popular choice again. But this episode shows how concerns about breast implant safety can lead to significant changes in the market and in medical practice.
The Story of Injectable Fillers
There were also issues with certain injectable fillers used for breast augmentation. In the past, substances like polyacrylamide gel (such as Olmedine in China) were used for breast augmentation. These substances were initially thought to be a convenient and effective way to enhance breast size. However, it was later discovered that they had serious problems. Polyacrylamide gel could break down in the body, releasing toxic monomers. It could also migrate within the body, causing problems such as the filler moving from the breast area to other parts, like the armpit or even the groin. In addition, it could cause inflammation, pain, and in some cases, there were concerns about potential long – term health risks, including cancer. As a result, products like Olmedine were banned in many countries, including China in 2006.
Conclusion
The recall of Allergan’s BIOCELL textured breast implants due to their potential link to BIA – ALCL was a significant event in the history of breast implant surgery. It brought to light the importance of implant safety and the need for continuous monitoring by health authorities. For patients with implanted BIOCELL products, regular follow – up is crucial to detect any potential issues early. For those considering breast implants, it serves as a reminder to thoroughly research and discuss all aspects of the implant, including its safety, with a qualified plastic surgeon. The history of breast implant recalls, from the silicone implant controversy to the problems with injectable fillers, shows that the field of cosmetic breast surgery is constantly evolving, with patient safety at the forefront of these changes.
Related topics:
4 Main Textured Breast Implants: Pros & Cons
All You Need To Know About What Are Sientra Breast Implants
5 Foods That Will Help You Recover After Breast Implants Come Out
